Ondansetron in a patient with porphyria

S Afr Med J. 1992 Dec;82(6):480.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Middle Aged
  • Ondansetron / adverse effects
  • Ondansetron / therapeutic use*
  • Porphyrias / chemically induced
  • Porphyrias / complications*

Substances

  • Antineoplastic Agents
  • Ondansetron